Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Determination of glycosaminoglycan levels by mass spectrometry

Determination of glycosaminoglycan levels by mass spectrometry

US Patent 10578624 · Granted Mar 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition and methods for treatment of ornithine transcarbamylase deficiency2025
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of 2022
Composition and methods for treatment of ornithine transcarbamylase deficiency2021
Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma2021
Amyloid precursor protein (APP) RNAi agent compositions and methods of use there2021
Mannose-6-phosphate bearing peptides fused to lysosomal enzymes2020
Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathe2020
Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of 2020
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of 2017
Method of identifying a modulator of a LTβR complex signaling pathway2007
Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass sp2006
Isotope-coded ionization-enhancing reagents (ICIER) for high-throughput protein 2005